Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapy associated leukaemia.

S Devereux1

  • 1Department of Haematology, Kent and Canterbury Hospital, UK.

Blood Reviews
|September 1, 1991
PubMed
Summary
This summary is machine-generated.

Certain cancer therapies, like chemotherapy and radiotherapy, can increase the risk of developing treatment-associated acute myeloid leukaemia (tAML) and myelodysplasia. These secondary cancers often present with severe blood count abnormalities and have a poor prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intraoperative needlescopy facilitates complete urolith removal during open cystotomy in dogs and cats: 19 cases.

The Journal of small animal practice·2026
Same author

Calcaneotibial screws for immobilisation of the tarsocrural joint of dogs in extension: effect of the angle of screw placement on the force to failure in a canine cadaveric model.

New Zealand veterinary journal·2021
Same author

Somatic CLL mutations occur at multiple distinct hematopoietic maturation stages: documentation and cautionary note regarding cell fraction purity.

Leukemia·2017
Same author

Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition.

Leukemia·2014
Same author

Analysis of a potential cluster of rhinovirus infections in patients and staff on two haemato-oncology wards.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2014
Same author

Lymphadenopathy and splenomegaly in an HIV-infected man.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2012
Same journal

Treating large B-cell lymphoma: Current strategies and unmet needs across community and academic settings.

Blood reviews·2026
Same journal

MRD in multiple myeloma: Moving from "minimal" to "measurable".

Blood reviews·2026
Same journal

PRISMA-based systematic review on iron stores in repeat blood donors.

Blood reviews·2026
Same journal

Artificial intelligence applications in thrombotic thrombocytopenic Purpura: A systematic review of diagnostic, risk stratification, and prognostic models.

Blood reviews·2026
Same journal

Antibacterial, antifungal and antiviral prophylaxis and vaccination strategies in adult patients with acute myeloid and promyelocytic leukemia: An expert panel consensus from the GIMEMA group.

Blood reviews·2026
Same journal

The Lebanese national patient blood management guidelines: A new page in the medical practice.

Blood reviews·2026
See all related articles

Area of Science:

  • Oncology
  • Hematology
  • Cancer Therapeutics

Background:

  • Certain cancer treatments, including alkylating agents and radiotherapy, are associated with a dose-related risk of secondary malignancies.
  • Treatment-associated acute myeloid leukaemia (tAML) and myelodysplasia share distinct biological and clinical features compared to de novo disorders.

Purpose of the Study:

  • To describe the characteristics, genetic abnormalities, and prognosis of treatment-associated acute myeloid leukaemia (tAML).
  • To highlight the distinct nature of tAML and myelodysplasia from de novo conditions.

Main Methods:

  • Review of clinical presentations and outcomes of patients with tAML.
  • Analysis of cytogenetic abnormalities, particularly involving chromosomes 5 and 7.
  • Correlation of genetic lesions with prognosis.

Related Experiment Videos

Main Results:

  • tAML typically occurs 2-11 years post-chemo/radiotherapy.
  • Common cytogenetic abnormalities include deletions on the long arm of chromosomes 5 or 7 (5q23-32 and 7q22-31).
  • Patients with tAML have a poor prognosis, with low remission rates and a median survival of 6 months, especially those with complex karyotypes or chromosome 5/7 lesions.

Conclusions:

  • tAML is a serious complication of cancer therapy with a poor outlook.
  • Genetic lesions, particularly involving chromosomes 5 and 7, are frequent and associated with worse prognosis.
  • The risks of therapy-induced tAML must be carefully weighed against treatment benefits.